$2.37
At close: Apr 9 EDT
$2.28
-0.09-3.79%
Pre-Market: 9:04 AM EDT
Comments
Loading...
Aquestive Therapeutics Stock Guidance | NASDAQ:AQST | Benzinga
Aquestive Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/05/2025 | AQST | Aquestive Therapeutics | FY | 2025 | — | — | — | $47.00M | $56.00M | $52.97M | Get Alert |
| 11/04/2024 | AQST | Aquestive Therapeutics | FY | 2024 | — | — | — | $57.00M | $60.00M | $58.01M | Get Alert |
| 09/27/2024 | AQST | Aquestive Therapeutics | FY | 2024 | — | — | — | $57.00M | $60.00M | $58.01M | Get Alert |
| 08/06/2024 | AQST | Aquestive Therapeutics | FY | 2024 | — | — | — | $57.00M | $60.00M | $49.79M | Get Alert |
| 05/07/2024 | AQST | Aquestive Therapeutics | FY | 2024 | — | — | — | $48.00M | $51.00M | $50.21M | Get Alert |
| 03/05/2024 | AQST | Aquestive Therapeutics | FY | 2024 | — | — | — | $48.00M | $51.00M | $48.10M | Get Alert |
| 11/06/2023 | AQST | Aquestive Therapeutics | FY | 2023 | — | — | — | $47.00M | $50.00M | $47.45M | Get Alert |
| 08/07/2023 | AQST | Aquestive Therapeutics | FY | 2023 | — | — | — | $44.00M | $48.00M | $43.37M | Get Alert |
| 05/02/2023 | AQST | Aquestive Therapeutics | FY | 2023 | — | — | — | $42.00M | $46.00M | $39.06M | Get Alert |
| 03/07/2023 | AQST | Aquestive Therapeutics | FY | 2023 | — | — | — | $37.00M | $41.00M | $37.83M | Get Alert |
| 11/01/2022 | AQST | Aquestive Therapeutics | FY | 2022 | — | — | — | $46.00M | $49.00M | $47.01M | Get Alert |
| 08/02/2022 | AQST | Aquestive Therapeutics | FY | 2022 | — | — | — | $46.00M | $49.00M | $46.46M | Get Alert |
| 05/03/2022 | AQST | Aquestive Therapeutics | FY | 2022 | — | — | — | $42.00M | $47.00M | $48.01M | Get Alert |
| 03/08/2022 | AQST | Aquestive Therapeutics | FY | 2022 | — | — | — | $42.00M | $47.00M | $62.68M | Get Alert |
| 11/02/2021 | AQST | Aquestive Therapeutics | FY | 2021 | — | — | — | $47.00M | $49.00M | $48.32M | Get Alert |
| 08/03/2021 | AQST | Aquestive Therapeutics | FY | 2021 | — | — | — | $46.00M | $48.00M | $40.07M | Get Alert |
| 05/04/2021 | AQST | Aquestive Therapeutics | FY | 2021 | — | — | — | $38.00M | $42.00M | $39.13M | Get Alert |
| 03/09/2021 | AQST | Aquestive Therapeutics | FY | 2021 | — | — | — | $38.00M | $42.00M | $41.19M | Get Alert |
| 11/04/2020 | AQST | Aquestive Therapeutics | FY | 2020 | — | — | — | $42.00M | $46.00M | $47.32M | Get Alert |
| 08/04/2020 | AQST | Aquestive Therapeutics | FY | 2020 | — | — | — | $35.00M | $45.00M | $38.42M | Get Alert |
FAQ
What is the most recent guidance for Aquestive Therapeutics (AQST)?
There have been no specific sales or earnings guidance reported for Aquestive Therapeutics in recent months.
Browse guidance and forecast on all stocks.